Jane Street Group, LLC Viking Therapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$49.84 - $70.47 $23.9 Million - $33.7 Million
478,800 New
478,800 $30.3 Million
Q4 2021

Feb 15, 2022
SELL
$4.6 - $6.72 $171,120 - $249,984
-37,200 Reduced 44.08%
47,200 $217,000
Q3 2021

Nov 16, 2021
SELL
$5.58 - $7.04 $114,948 - $145,024
-20,600 Reduced 19.62%
84,400 $530,000
Q2 2021

Aug 16, 2021
SELL
$5.19 - $6.73 $48,267 - $62,589
-9,300 Reduced 8.14%
105,000 $629,000
Q1 2021

May 18, 2021
BUY
$5.74 - $9.67 $225,008 - $379,064
39,200 Added 52.2%
114,300 $723,000
Q4 2020

Feb 17, 2021
SELL
$5.3 - $6.71 $461,100 - $583,770
-87,000 Reduced 53.67%
75,100 $423,000
Q3 2020

Nov 17, 2020
SELL
$5.73 - $8.11 $961,494 - $1.36 Million
-167,800 Reduced 50.86%
162,100 $943,000
Q2 2020

Aug 17, 2020
BUY
$4.35 - $8.08 $1.37 Million - $2.55 Million
315,200 Added 2144.22%
329,900 $2.38 Million
Q1 2020

May 15, 2020
SELL
$3.45 - $7.95 $182,850 - $421,350
-53,000 Reduced 78.29%
14,700 $69,000
Q1 2019

May 16, 2019
BUY
$7.58 - $9.94 $366,114 - $480,102
48,300 Added 248.97%
67,700 $673,000
Q4 2018

Feb 15, 2019
BUY
$7.16 - $16.21 $28,640 - $64,840
4,000 Added 25.97%
19,400 $148,000
Q3 2018

Nov 14, 2018
BUY
$9.7 - $19.65 $149,380 - $302,610
15,400 New
15,400 $268,000

Others Institutions Holding VKTX

# of Institutions
473
Shares Held
66.2M
Call Options Held
5.72M
Put Options Held
3.39M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.03B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email